BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 716292)

  • 1. [Specific features of measles in vaccinated children].
    Loseva AG; Peĭzner EM
    Vopr Okhr Materin Det; 1978 Sep; 23(9):49-50. PubMed ID: 716292
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 3. Measles antibody response in vaccinated children.
    Evliyaoğlu N; Altintaş D; Kiliç NB; Alhan SE; Onenli N; Güneşer S; Bahçebaşi T
    Turk J Pediatr; 1996; 38(3):315-21. PubMed ID: 8827900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
    Wiedermann G; Ambrosch F
    Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-immunological characteristics of measles in children vaccinated with a live measles vaccine].
    Smorodinova IP; Shikina ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():102-8. PubMed ID: 4808371
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
    Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS; Halpin TJ; Orenstein WA
    Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misplaced loss of confidence in measles vaccination: an investigation in a primary school.
    Hicks NR
    J R Coll Gen Pract; 1989 Apr; 39(321):151-2. PubMed ID: 2559990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.